Clinical Trials Logo
  1. Home
  2. Uterine Neoplasms
  3. NCT00782041

Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer

Uterine Neoplasms Clinical Trial

Official title:
Phase II Study of Oxaliplatin in Combination With 5-fluorouracil (5-FU) and Folinic Acid (FA) in Patients Who Have Failed First-line Treatment for Locally Advanced or Metastatic Cervical Cancer.

Clinical Trial Summary

Primary:

- To assess the overall response rate of oxaliplatin in patients with bidimensionally measurable disease at baseline.

Secondary:

- To assess the safety and tolerability of oxaliplatin

- To assess time to progression and overall survival.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00782041
Study type Interventional
Source Sanofi
Contact
Status Terminated
Phase Phase 2
Start date January 2003
View Details
See also
  Status Clinical Trial Phase
Completed NCT02374411 - Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients N/A
Completed NCT00377520 - A Trial for Patients With Advanced/Recurrent Endometrial Cancer Phase 2
Recruiting NCT04063072 - ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy. N/A
Terminated NCT01969396 - Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology N/A
Terminated NCT00669422 - ChemoFx® PRO - A Post-Market Data Collection Study N/A
Recruiting NCT01564264 - Sentinel Node Biopsy in Endometrial Cancer N/A
Completed NCT00231855 - Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers Phase 2
Completed NCT04679675 - Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial N/A
Completed NCT04351139 - Impact of the COVID-19 Pandemic in Gynecological Oncology
Completed NCT05004623 - Early Feasibility Study of the "Easy Light" Fluorecence Imaging System N/A
Completed NCT00112307 - Magnetic Resonance Imaging Guided Gynecologic Brachytherapy N/A
Completed NCT02454036 - Biobehavioral Intervention in Gynecologic Oncology Patients Phase 2
Completed NCT00188578 - Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2) Phase 1/Phase 2
Active, not recruiting NCT03951415 - Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer Phase 2
Completed NCT01654458 - A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer N/A
Completed NCT00190918 - A Trial for Patients With Gestational Trophoblastic Disease Phase 2
Completed NCT00050440 - Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma Phase 2
Completed NCT00250783 - Pre-Clinical Models in Gynecological Tumors A Tissue Repository
Recruiting NCT03624712 - Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms
Completed NCT00628901 - A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) Phase 4